Quantcast
Last updated on April 19, 2014 at 8:45 EDT

Latest Tamsulosin Stories

2013-06-12 04:22:03

DUBLIN, June 12, 2013 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/3c9pm9/research_report) has announced the addition of the "Research Report on China's Anti-Prostatic Hyperplasia (PH) Drug Market, 2013-2017" [http://www.researchandmarkets.com/research/3c9pm9/research_report ] report to their offering. <start_newscom> (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Benign prostatic hyperplasia (BPH) is a common...

2012-10-26 04:03:51

The online Canadian pharmacy provider Big Mountain Drugs is offering a promo coupon code bph10 for medications that may help men maintain a healthier prostate. Vancouver, BC (PRWEB) October 25, 2012 Taking care of your health is important. Big Mountain Drugs, a reputable online Canadian pharmacy and international drugstore, is proud to support the health needs of men by offering a coupon, promo code bph10, helping to make certain medications more affordable. When roughly 50% of men over age...

2012-02-07 07:00:00

INDIANAPOLIS, Feb. 7, 2012 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced today that a Phase III study, published online by European Urology, showed both Cialis® (tadalafil) and tamsulosin significantly improved scores on the International Prostate Symptom Score (IPSS), compared to placebo, in men with signs and symptoms suggestive of benign prostatic hyperplasia (BPH). Cialis improved erectile dysfunction (ED) in those men who had both signs and symptoms of BPH...

2011-10-06 15:58:00

SILVER SPRING, Md., Oct. 6, 2011 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration today approved Cialis (tadalafil) to treat the signs and symptoms of benign prostatic hyperplasia (BPH), a condition in which the prostate gland becomes enlarged, and for the treatment of BPH and erectile dysfunction (ED), when the conditions occur simultaneously. Cialis was approved in 2003 for the treatment of ED. (Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO) Common symptoms...

Study Confirms Monday Is The Most Dreaded Day Of The Week
2011-09-12 10:51:40

  According to a new study, one in three people say they hate Monday more than any other day in the week. Flomax Relief conducted a survey of 2,000 adults who said they spent 34 minutes complaining on a Monday morning, compared to just 22 minutes during the rest of the week. The study found that the most common reasons include dreading the work week ahead, over-indulging over the weekend or having plenty of emails to have to catch up to. A spokesman for Flomax Relief, which...

2011-07-22 16:13:00

PARSIPPANY, N.J., July 22, 2011 /PRNewswire/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI) today confirmed that its subsidiary, Watson Laboratories, Inc. - Florida, filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market dutasteride and tamsulosin hydrochloride capsules. Watson's dutasteride and tamsulosin hydrochloride capsules are a generic version of GlaxoSmithKline's JALYN(TM). JALYN(TM) capsules are indicated for the...

2011-01-26 19:28:00

LONDON and PHILADELPHIA, Jan. 26, 2011 /PRNewswire/ -- GlaxoSmithKline (GSK) today announced that the Company has received a Complete Response letter from the U.S. Food and Drug Administration (FDA) for the supplemental New Drug Application (sNDA) for Avodart® (dutasteride) for reducing the risk of prostate cancer in men at increased risk for the disease, defined as those who have had a prior negative biopsy due to clinical concern and have an elevated serum...

2010-07-22 08:05:00

DETROIT, July 22 /PRNewswire-FirstCall/ -- Caraco Pharmaceutical Laboratories, Ltd. (NYSE Amex: CPD) has started shipping tamsulosin hydrochloride capsules. This product was recently approved by the US Food and Drug Administration (FDA) for Sun Pharma's Abbreviated New Drug Application (ANDA). These tamsulosin hydrochloride capsules are therapeutically equivalent to Flomax® Capsules 0.4 mg from Boehringer Ingelheim Pharmaceuticals, Inc. Tamsulosin hydrochloride capsules...

2010-04-28 06:30:00

PITTSBURGH, April 28 /PRNewswire-FirstCall/ -- Mylan Inc. (Nasdaq: MYL) today announced that its subsidiary Mylan Pharmaceuticals Inc. received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Tamsulosin Hydrochloride Capsules USP, 0.4 mg, the generic version of Boehringer Ingelheim's benign prostatic hyperplasia (BPH) treatment, Flomax®. Tamsulosin Hydrochloride Capsules had U.S. sales of approximately...

2010-04-27 16:00:00

MORRISTOWN, N.J., April 27 /PRNewswire/ -- Actavis Inc., today began shipping Tamsulosin capsules to its customers in the United States. The generic equivalent to Flomax®, Tamsulosin is used to treat benign prostatic hyperplasia (BPH). Actavis is partnering with Synthon Pharmaceuticals to launch and market Tamsulosin capsules in the United States. Actavis offers Tamsulosin in a 0.4 mg strength capsule. Annual sales of Flomax® capsules in the U.S. were...